Related Experiment Video

Updated: May 26, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

P21-activated kinase 4 overexpression in metastatic gastric cancer patients

Hee Kyung Ahn1, Jiryeon Jang, Jeeyun Lee

  • 1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Translational Oncology
|December 23, 2011
PubMed
Abstract

Insights

P21-activated kinase 4 (PAK4) is overexpressed in some metastatic gastric cancers. This overexpression may indicate poorer survival and resistance to chemotherapy, suggesting PAK4 as a potential drug target for gastric cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • P21-activated kinase 4 (PAK4) is a serine/threonine kinase involved in cytoskeletal dynamics and cell motility.
  • PAK4 has emerged as a key player in oncogenic signaling pathways.
  • This study investigates the role of PAK4 in metastatic gastric cancer.

Purpose of the Study:

  • To determine the frequency of PAK4 overexpression in metastatic gastric cancer.
  • To explore the clinical features associated with PAK4 overexpression.
  • To assess the potential of PAK4 as a prognostic marker and therapeutic target.

Main Methods:

  • Western blot analysis was used to screen PAK4 expression in 18 gastric cancer cell lines.
  • Immunohistochemical staining assessed PAK4 protein levels in 49 metastatic gastric cancer patient specimens.
  • PAK4 knockdown using small interfering RNA was performed in vitro.

Main Results:

  • PAK4 protein overexpression was detected in several gastric cancer cell lines.
  • Immunohistochemistry revealed PAK4 overexpression in 8.1% of metastatic gastric cancer specimens.
  • Patients with PAK4-overexpressing tumors showed no response to capecitabine/cisplatin and a trend towards poorer survival.

Conclusions:

  • PAK4 is overexpressed in a subset of gastric cancer patients, suggesting a role in tumorigenesis.
  • PAK4 overexpression may serve as a negative prognostic indicator.
  • Further research is warranted to validate PAK4's prognostic significance and therapeutic potential.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...